Wednesday, November 15, 2017 • 5:30 - 9:00 PM
STATE OF THE SCIENCE SUMMIT: Advanced Non-Small Cell Lung Cancer
Wednesd ay, Nov em b er 15, 2017 • 5: 30 - 9: 00 P M LOCATION: Le Meridien Charlotte 555 South McDowell Street North Tower Charlotte, NC 28204
PROGRAM CHAIR: Edward Kim, MD Chair, Solid Tumor Oncology and Investigational Therapeutics Donald S. Kim Distinguished Chair for Cancer Research
Presenters
TOPICS OF DISCUSSION:
Daniel Haggstrom, MD John Heinzerling, MD
• Landscape of Lung Cancer • Biomarkers in NSCLC: Which Ones and How? • When to Biopsy and When to Utilize Liquid Biopsies in Lung Cancer • Targeted Therapies in NSCLC: EGFR, ALK and Others • Potential Use of Immunotherapy for Stage III Locally Advanced Disease • Combination Strategies with Immunotherapy in Frontline NSCLC • Other Targets in Lung Cancer (BRAF, TRK, MSI) • Question & Answer Sessions
Raghava Induru, MD Kathryn Mileham, MD Jared Weiss, MD
levinecancerinstitute.org To register, please contact Allison Cooper at: [email protected] or visit: www.onclive.com/meetings/soss
Wednesd ay, Nov em b er 15, 2017 • 5: 30 - 9: 00 P M LOCATION: Le Meridien Charlotte 555 South McDowell Street North Tower Charlotte, NC 28204
PROGRAM CHAIR: Edward Kim, MD Chair, Solid Tumor Oncology and Investigational Therapeutics Donald S. Kim Distinguished Chair for Cancer Research
Presenters
TOPICS OF DISCUSSION:
Daniel Haggstrom, MD John Heinzerling, MD
• Landscape of Lung Cancer • Biomarkers in NSCLC: Which Ones and How? • When to Biopsy and When to Utilize Liquid Biopsies in Lung Cancer • Targeted Therapies in NSCLC: EGFR, ALK and Others • Potential Use of Immunotherapy for Stage III Locally Advanced Disease • Combination Strategies with Immunotherapy in Frontline NSCLC • Other Targets in Lung Cancer (BRAF, TRK, MSI) • Question & Answer Sessions
Raghava Induru, MD Kathryn Mileham, MD Jared Weiss, MD
levinecancerinstitute.org To register, please contact Allison Cooper at: [email protected] or visit: www.onclive.com/meetings/soss
